-
Dec 03, 2024Drug Delivery Strategies For Brain DiseasesExplore the latest advancements in drug delivery strategies for brain diseases, including non-invasive, invasive, and emerging techniques, and their potential to overcome the bl... -
Nov 28, 2024Real-time Intraoperative MRI Navigation: Supporting FDA Approval Of The First...Explore Prisys Biotech's pioneering use of real-time intraoperative MRI (RT-iMRI) technology for precision brain delivery. Learn how this breakthrough supported FDA approval of ... -
Nov 26, 2024Ocular Toxicity Studies Of Eye Drops: Drug Exposure And Safety EvaluationExplore ocular toxicity studies for eye drops, focusing on drug exposure, transport mechanisms, and safety evaluations. Learn about the implications for anterior and posterior s... -
Nov 19, 2024Prisys Biotech Establishes Cynomolgus Monkey Psoriasis Model To Accelerate Dr...Discover Prisys Biotech's innovative cynomolgus monkey psoriasis model, a breakthrough in preclinical drug research that simulates human pathophysiology for effective psoriasis ... -
Nov 15, 2024Comprehensive Non-Human Primate Models For Renal Disease Research By Prisys B...Explore Prisys Biotech's comprehensive non-human primate (NHP) renal disease models designed for acute kidney injury (AKI) and chronic kidney disease (CKD) research. Our models ... -
Nov 11, 2024Comprehensive Preclinical Safety Evaluation Of Antibody-Drug Conjugates (ADCs...Prisys Biotech excels in preclinical ADC safety evaluations using non-human primate models, offering insights into ADC toxicokinetics, immunogenicity, tissue cross-reactivity, a... -
Nov 08, 2024Pharmacokinetics Evaluation Of Antibody-Drug Conjugates (ADCs) in Non-Human P...Explore Prisys Biotech's advanced expertise in ADC pharmacokinetics evaluation using non-human primate models. Our CRO specializes in comprehensive PK analysis, stability studie... -
Nov 06, 2024Pharmacodynamics Evaluation Of ADCsPrisys Biotech leads in ADC pharmacodynamics evaluation using advanced disease modeling in non-human primates. Our comprehensive assessment solutions span target affinity testin... -
Oct 29, 2024Understanding The DMPK Of ADC DrugsA comprehensive overview of the pharmacokinetics and distribution-elimination processes in ADC drugs, highlighting critical factors influencing ADC performance and therapeutic w... -
Oct 17, 2024Progress in The Development Of Nucleic Acid Drugs And Prisys Biotech’s Resear...To highlight Prisys Biotech's cutting-edge capabilities in nucleic acid drug development and preclinical pharmacology, focusing on challenges and research solutions in delivery,... -
Oct 12, 2024Advances in mRNA Pulmonary Delivery Systems And Prisys biotech's Innovative S...An overview of the latest advancements in mRNA pulmonary delivery systems, highlighting PuLing Bio's contributions with non-human primate disease models and specialized techniqu... -
Oct 08, 2024Why Was The 2024 Nobel Prize in Physiology Or Medicine Awarded To These Two S...Discover the groundbreaking work of Victor Ambros and Gary Ruvkun, recipients of the 2024 Nobel Prize in Physiology or Medicine, for their discovery of microRNA and its role in ...
